Farmaceutica Remedia (BSE:RMAH) 3-Year Book Growth Rate : 15.70% (As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia 3-Year Book Growth Rate?

Farmaceutica Remedia's Book Value per Share for the quarter that ended in Sep. 2023 was lei0.70.

During the past 12 months, Farmaceutica Remedia's average Book Value per Share Growth Rate was 0.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 15.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 14.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Farmaceutica Remedia was 21.40% per year. The lowest was -1.60% per year. And the median was 6.30% per year.

Competitive Comparison of Farmaceutica Remedia's 3-Year Book Growth Rate

For the Medical Distribution subindustry, Farmaceutica Remedia's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farmaceutica Remedia's 3-Year Book Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's 3-Year Book Growth Rate falls into.

Farmaceutica Remedia 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Farmaceutica Remedia (BSE:RMAH) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Farmaceutica Remedia 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Farmaceutica Remedia (BSE:RMAH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040

Website

https://corporate.remedia.ro

Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines